Lenka Hovorková

Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology

Lenka Hovorková, Markéta Žaliová, Nicola C. Venn et al. · Blood · 2017 · 128 citations · Full text

Minimal residual disease in BCR::ABL1-positive acute lymphoblastic leukemia: different significance in typical ALL and in CML-like disease

Jan Zuna, Lenka Hovorková, Justina Krotka et al. · Leukemia · 2022 · 51 citations

Hematological Malignancy, Different Significance, Medicine +10

<i>ERG</i> deletions in childhood acute lymphoblastic leukemia with <i>DUX4</i> rearrangements are mostly polyclonal, prognostically relevant and their detection rate strongly depends on screening method sensitivity

Markéta Žaliová, Eliška Potůčková, Lenka Hovorková et al. · Haematologica · 2019 · 44 citations · Full text

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

Kateřina Machová Poláková, Hana Žižková, Jan Zuna et al. · Leukemia · 2020 · 29 citations

Hematological Malignancy, Engineering, Genomic Pcr +13

Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase

Kateřina Hložková, Alena Pecinová, Natividad Alquézar-Artieda et al. · BMC Cancer · 2020 · 29 citations · Full text